SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-3 - Registration statement under Securities Act of 1933:
SEC Accession No. 0001437749-23-005232
Filing Date
2023-03-02
Accepted
2023-03-02 16:35:04
Documents
5

Document Format Files

Seq Description Document Type Size
1 FORM S-3 vtgn20230228_s3.htm S-3 402514
2 EXHIBIT 23.2 ex_482029.htm EX-23.2 2867
3 EXHIBIT 23.3 ex_482031.htm EX-23.3 2599
4 EXHIBIT FILING FEES ex_482030.htm EX-FILING FEES 31370
5 vtgn.jpg GRAPHIC 10015
  Complete submission text file 0001437749-23-005232.txt   448905
Mailing Address 343 ALLERTON AVENUE SOUTH SAN FRANCISCO CA 94080
Business Address 343 ALLERTON AVENUE SOUTH SAN FRANCISCO CA 94080 650-577-3600
VistaGen Therapeutics, Inc. (Filer) CIK: 0001411685 (see all company filings)

IRS No.: 205093315 | State of Incorp.: NV | Fiscal Year End: 0331
Type: S-3 | Act: 33 | File No.: 333-270232 | Film No.: 23699629
SIC: 2834 Pharmaceutical Preparations